Current Affairs
Daily Bits

WHO suspends clinical trial of Hydroxychloroquine on COVID-19 patients

  • Posted By
    10Pointer
  • Categories
    Science & Technology
  • Published
    27th May, 2020
  • The World Health Organization (WHO) Director General said that it has temporarily suspended the clinical trial of Hydroxychloroquine (HCQ) on COVID-19 patients.
  • The Lancet Medical Journal published an observational study on HCQ and chloroquine and its effect on COVID-19 patients, who were hospitalized.
  • The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.
  • WHO had initiated the Solidarity Trial, to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19, which include HCQ.
  • The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met earlier this week and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally.
  • The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug.

Verifying, please be patient.